SCHEMBL6650557

SCHEMBL6650557

C1NC2NCNC2N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16081359 0.87
SCHEMBL15291780 0.71
SCHEMBL18903445 0.63
SCHEMBL2142300 0.58
SCHEMBL182191 0.45
SCHEMBL44386 0.41
Methane SCHEMBL23795058 0.33
SCHEMBL6532140 0.33
SCHEMBL2001931 0.33
SCHEMBL7860202 0.33

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1032387-A4 NOVEL METAL COMPLEXES SMITHKLINE BEECHAM CORP (US) 2004-02-11 EP disclosed
EP-1039906-A4 NOVEL METAL COMPLEXES SMITHKLINE BEECHAM CORP (US) 2004-02-11 EP disclosed
EP-1080093-A4 G-CSF MIMETICS SMITHKLINE BEECHAM CORP (US) 2002-10-28 EP disclosed
EP-1032388-A4 NOVEL METAL COMPLEXES SMITHKLINE BEECHAM CORP (US) 2002-10-02 EP disclosed
US-6413952-B1 FORMING METAL-CHELATE COMPOUND SMITHKLINE BEECHAM CORPORATION 2002-07-02 US disclosed
US-6280959-B1 Zinc chelated cell surface receptor ligands for use as agonist of dimeric cell surface receptors; for example, 2-bis(2,5-bis(2-benzimidazolylimino)-3A,6A-diphenyl-1,2,3,3a, 4,5,6,6a-octahydroimidazo(4,5-d)imidazole-N,N')-zinc(II) SMITHKLINE BEECHAM CORPORATION 2001-08-28 US disclosed
EP-0920314-A4 NON-PEPTIDE G-CSF MIMETICS SMITHKLINE BEECHAM CORP (US) 2001-08-16 EP disclosed
US-6211200-B1 ADMINISTERING ZINC CHELATED IMIDAZO(4,5-D)IMIDAZOLE COMPOUNDS AS GRANULOCYTE COLONY STIMULATING FACTOR AGONISTS SMITHKLINE BEECHAM CORPORATION 2001-04-03 US disclosed
EP-1080093-A1 G-CSF MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 2001-03-07 EP disclosed
EP-1039906-A1 NOVEL METAL COMPLEXES SMITHKLINE BEECHAM CORPORATION (US) 2000-10-04 EP disclosed
EP-1032388-A1 NOVEL METAL COMPLEXES SMITHKLINE BEECHAM CORPORATION (US) 2000-09-06 EP disclosed
EP-1032387-A1 NOVEL METAL COMPLEXES SMITHKLINE BEECHAM CORPORATION (US) 2000-09-06 EP disclosed
WO-1999061445-A1 G-CSF MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 1999-12-02 WO disclosed
US-5981551-A GRANULOCYTE COLONY-STIMULATING FACTOR MIMETICS; TREATMENT OF NEUTROPENIA SMITHKLINE BEECHAM CORPORATION (US) 1999-11-09 US disclosed
EP-0920314-A1 NON-PEPTIDE G-CSF MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 1999-06-09 EP disclosed
WO-1999022734-A1 NOVEL METAL COMPLEXES SMITHKLINE BEECHAM CORPORATION (US) 1999-05-14 WO disclosed
WO-1999022732-A1 NOVEL METAL COMPLEXES SMITHKLINE BEECHAM CORPORATION (US) 1999-05-14 WO disclosed
WO-1999022733-A1 NOVEL METAL COMPLEXES SMITHKLINE BEECHAM CORPORATION (US) 1999-05-14 WO disclosed
WO-1997044033-A1 NON-PEPTIDE G-CSF MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 1997-11-27 WO disclosed